Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josephine Mauskopf

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2010
Reflecting on my 8 years. EditorialJosephine Mauskopf
Pharmacoeconomics|April 19, 2014
Modelling technique, structural assumptions, input parameter values: which has the most impact on the results of a cost-effectiveness analysis?Josephine Mauskopf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the FutureJosephine Mauskopf
Pharmacoeconomics|November 16, 2013
A methodological review of models used to estimate the cost effectiveness of antiretroviral regimens for the treatment of HIV infectionJosephine Mauskopf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2003
Value in health: "bridging the gap" among our disciplinesJosephine Mauskopf
Pharmacoeconomics|June 24, 2016
A Methodological Review of US Budget-Impact Models for New DrugsJosephine Mauskopf, Stephanie Earnshaw
American Journal of Alzheimer'S Disease and Other Dementias|May 13, 2011
A review of the methods used to estimate the cost of Alzheimer's disease in the United StatesJosephine Mauskopf, Lisa Mucha
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 17, 2017
The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challengesSalah Ghabri, Josephine Mauskopf
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?Josephine Mauskopf, Catherine Masaquel, Liping Huang
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2010
Reflecting on my 8 years. EditorialJosephine Mauskopf
Pharmacoeconomics|April 19, 2014
Modelling technique, structural assumptions, input parameter values: which has the most impact on the results of a cost-effectiveness analysis?Josephine Mauskopf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2019
Multivariable and Structural Uncertainty Analyses for Cost-Effectiveness Estimates: Back to the FutureJosephine Mauskopf
Pharmacoeconomics|November 16, 2013
A methodological review of models used to estimate the cost effectiveness of antiretroviral regimens for the treatment of HIV infectionJosephine Mauskopf
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2003
Value in health: "bridging the gap" among our disciplinesJosephine Mauskopf
Pharmacoeconomics|June 24, 2016
A Methodological Review of US Budget-Impact Models for New DrugsJosephine Mauskopf, Stephanie Earnshaw
American Journal of Alzheimer'S Disease and Other Dementias|May 13, 2011
A review of the methods used to estimate the cost of Alzheimer's disease in the United StatesJosephine Mauskopf, Lisa Mucha
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 17, 2017
The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challengesSalah Ghabri, Josephine Mauskopf
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 12, 2021
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?Josephine Mauskopf, Catherine Masaquel, Liping Huang
Pageof 10